Clinical trial

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

NCT06262386

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-08-01

PhaseNA

Study timeline

Study start (actual)2023-08-01Date precision: day

Registry last updated2024-02-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Relapse/Recurrenceunresolved

Interventions

Cisplatin based chemottherapyDRUG

Sponsors & collaborators

Chang Gung Memorial Hospitallead sponsor

National Science and Technology Councilcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06262386 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.